Full-Time

Wholesale Account Executive

Wholesale

Posted on 9/11/2026

Curaleaf

Curaleaf

1,001-5,000 employees

Cannabis cultivation, processing, and retailing

Compensation Overview

$90k - $100k/yr

No H1B Sponsorship

New York, NY, USA

Remote

Must be located in the Bronx or Manhattan and travel throughout the assigned territory, including occasional overnight stays.

Bachelor's

Category
Sales & Account Management (1)
Required Skills
Microsoft Office
Inventory Management
CRM
Word/Pages/Docs
Excel/Numbers/Sheets
PowerPoint/Keynote/Slides

Get referred to Curaleaf

See people who can refer or advise you

Requirements
  • A bachelor's degree (BA or BS) or equivalent experience.
  • At least 2 years of experience in wholesale and business-to-business sales in the natural products, cannabis, beverage, alcohol, or consumer packaged goods industries.
  • Demonstrated ability to develop and execute regional sales strategies.
  • Strong analytical skills with experience in sales reporting and forecasting.
  • Experience organizing promotional events and collaborating with marketing teams.
  • A proven track record of meeting or exceeding sales targets and key performance indicators.
  • Strong interpersonal and communication skills with the ability to build and maintain client relationships.
  • Proficiency in customer relationship management systems and Microsoft Office Suite, including Excel, PowerPoint, and Word.
  • Ability to travel frequently within the assigned territory, including occasional overnight stays.
  • A valid driver's license and reliable transportation.
  • Ability to coordinate multiple projects and meet deadlines.
  • Experience driving and exceeding sales quotas.
  • Excellent organizational, communication, and problem-solving skills.
  • Ability to recognize and respond to changing trends and priorities.
  • Ability to work in and foster a collaborative team environment.
  • Reliable transportation and ability to travel 100% of the time throughout the designated region.
Responsibilities
  • Manage all sales efforts for wholesale accounts throughout the state to achieve monthly and annual sales revenue and gross margin targets.
  • Partner with the local market team to develop state-specific strategies.
  • Conduct sales calls and selling efforts for wholesale accounts.
  • Develop and nurture new accounts and key customer relationships.
  • Develop pipelines, targets, and innovative strategies to increase opportunities and sales in the market.
  • Create and organize promotional events, update sales menus and product availability databases, and execute customer orders.
  • Work with the marketing team to develop promotional plans, campaigns, and educational initiatives to attract and capture new customers.
  • Prepare and present sales reports to track leads and execute follow-up.
  • Ensure proper inventory levels are maintained through sales tools, communication, and in-store visits.
  • Stay current on the industry, customer, and competitive product landscape.
  • Maintain regular communication with customers to understand their needs.
  • Build a strong base of industry expertise.
  • Attend cannabis industry trade shows, conferences, conventions, and other professional events to stay current on industry trends and interact with potential and existing customers.
  • Travel throughout the assigned territory, including occasional overnight stays.
  • Perform other duties as assigned.
Desired Qualifications
  • Knowledge of the cannabis industry, regulations, market trends, and competition.
  • Wholesale experience, preferably in the cannabis, consumer packaged goods, beverage, or natural products industries.
  • Experience working with dispensaries, distributors, or retail buyers.
  • A solid understanding of the cannabis industry and its laws, rules, and regulations, with the ability to stay current on industry changes.

Curaleaf is a cannabis company that grows, processes, and sells cannabis products for medical and recreational use. It offers items such as tinctures, flowers, and edibles, and uses encapsulation technology to improve product absorption and effectiveness. Customers can buy at dispensaries or online, and the company also provides medical consultations and guidance services. Differentiators include its vertically integrated model (cultivation, processing, and retail) and its social responsibility efforts, such as the B NOBLE program that supports individuals with cannabis-related non-violent charges. The company’s goal is to provide reliable cannabis products and related services to a wide range of customers while advancing responsible access and advocacy through programs like B NOBLE.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Wakefield, Massachusetts

Founded

2010

Get referred to Curaleaf

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q2 2026 revenue reached $340 million, up 10%, with $12 million net income.
  • International revenue rose 26% to $51 million, driven by Germany, the U.K., and Poland.
  • Florida openings in July 2026 and September 2026 keep same-state retail momentum strong.

What critics are saying

  • Aurora's September 2026 rejection frames Curaleaf's hostile bid as debt-driven desperation.
  • Curaleaf carried $611.5 million debt and only $107 million cash on June 30, 2026.
  • A failed Aurora deal leaves Curaleaf exposed to slower U.S. growth and refinancing pressure.

What makes Curaleaf unique

  • Curaleaf built a 167-store footprint by September 2026, with 76 Florida locations.
  • Its July 2026 Spain AEMPS registration made Curaleaf first for standardized cannabis preparations.
  • Germany's Four 20 Pharma ownership gives Curaleaf EU-GMP production and distribution leverage.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Paid Vacation

Parental Leave

401(k) Retirement Plan

Life Insurance

Disability Insurance

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Yahoo Finance
Sep 2nd, 2026
Curaleaf opens Boston dispensary near Downtown Crossing with expanded retail space

Curaleaf Holdings has opened a new cannabis dispensary in downtown Boston at 21 Milk St., near Downtown Crossing. The location opened on 4 September, offering patients expanded retail space and a broader selection of products. The dispensary will stock Curaleaf's portfolio of cannabis brands, including Dark Heart, Select, FIND, Anthem and Grassroots. Knowledgeable staff will assist customers in selecting products suited to their needs. A grand opening celebration is scheduled for 8 September, featuring in-store promotions, a Meet the Grower event, and brand activations. The store operates from 09:00 to 20:00 Monday through Saturday, and 09:00 to 18:00 on Sunday. The opening follows the closure of Curaleaf's former Provincetown dispensary.

Yahoo Finance
Aug 18th, 2026
Curaleaf launches $4 hostile bid for Aurora Cannabis to access EU medical market

Curaleaf has formally launched its hostile takeover bid for Aurora Cannabis, offering $4 per share directly to shareholders. The offer represents a 45% premium on Aurora's 30-day average share price from 10 August, before Curaleaf announced its intentions. The proposed deal would create a combined company with a $3 billion market cap. Curaleaf projects approximately $40 million in annual cost synergies from the merger. The acquisition aims to give Curaleaf access to EU medical cannabis export markets, particularly Germany. Aurora possesses EU-GMP cultivation capacity that meets strict German import standards. Federal restrictions make direct cannabis exports challenging for US firms like Curaleaf. Curaleaf CEO Boris Jordan said initial friendly discussions with Aurora CEO Miguel Martin earlier this summer stalled, prompting the direct shareholder approach. Aurora's board has formed a special committee to review the offer.

PR Newswire
Aug 5th, 2026
Curaleaf reports $340M Q2 revenue with 10% growth and $12M net income

Curaleaf Holdings reported second quarter 2026 revenue of $340 million, representing 10% year-over-year growth driven by domestic and international segments that grew 7% and 26%, respectively. International revenue reached $51 million. The cannabis company posted net income of $12 million and adjusted EBITDA of $70 million, reflecting a 21% margin. Gross profit margin stood at 50%. Chairman and CEO Boris Jordan said the results demonstrate the company's "Built for Growth" strategy is gaining traction. He noted this marks the second consecutive quarter of domestic year-over-year growth. Curaleaf ended the quarter with $107 million in cash and $611.5 million in outstanding debt. The company invested $32.9 million in capital expenditures during the six-month period, focused on facility upgrades and automation.

PR Newswire
Jul 29th, 2026
Curaleaf opens 75th Florida dispensary, expanding US footprint to 167 locations

Curaleaf Holdings has opened its 75th dispensary in Florida, located in Boynton Beach. The cannabis retailer now operates 167 locations nationwide, with Florida representing nearly half of its retail footprint. The new store at 3575 W. Boynton Beach Boulevard is the company's sixth Florida opening this year. It offers medical cannabis products including Anthem pre-rolls, Dark Heart ultra-premium flower, and Select vaping products. Boris Jordan, chairman and CEO, said the opening reinforces Curaleaf's commitment to expanding access to cannabis products across Florida. A grand opening celebration is scheduled for 31 July and 1 August, featuring special promotions and giveaways. The dispensary operates 9:00 to 20:30 Monday through Saturday, and 10:00 to 18:00 on Sunday.

Yahoo Finance
Jul 13th, 2026
Curaleaf becomes first company to register standardised cannabis preparations in Spain

Curaleaf Holdings has become the first company to secure registration for standardised cannabis preparations in Spain under the country's new regulatory framework, Royal Decree 903/2025. Spain's medicines agency AEMPS approved two preparations — THC-dominant and CBD-dominant — developed by Curaleaf's Spanish manufacturing subsidiary. The registrations enable supply to hospital pharmacies, where the preparations can be used in magistral formulas under medical prescription. Royal Decree 903/2025, approved in October 2025, establishes Spain's regulatory framework for medicinal cannabis, setting production and quality standards. Curaleaf operates an EU-GMP certified manufacturing facility and R&D laboratory in Alicante. The company secured Spain's first licence to process medicinal cannabis derivatives for commercial distribution in May 2020. The preparations are expected to become available to patients through hospital pharmacies as Spain's regulated system develops.